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Two main types of proteins are associated with chromatin. The histones are a 
well characterized group of basic  proteins,  which  seem to be involved in the 
general organization of the chromatin.  The nonhistone proteins  (NHP)  ~ are a 
much more heterogeneous group of proteins and are believed to be involved in 
the regulation of gene expression (1, 2). 
If gene expression is related to the composition of the NHP fraction, qualitative and 
quantitative changes in this composition should occur during normal differentiation, 
accompanying changes in growth state of cells and during carcinogenesis. Experimental 
evidence obtained by gel electrophoresis (3) and especially by comparison of  the antigenic 
properties of NHP from various sources has berne out this suggestion (4). 
Comparison of NHP of a  given normal tissue  or cultured coils and its  malignant 
counterpart also reveals extensive antigenic differences (5-8).  These early studies were 
carried out by using complement fixation tests with the whole NHP fraction as antigen. 
The individual components of NHP were not identified. More recently, Yeoman et al. (9) 
have isolated and characterized a nonhistone protein antigen present in rat hepatomas, 
but absent in the normal liver. This protein also seemed to be present in the fetal liver. In 
this sense it resembles the oncofetal proteins such as alphafetoprotein (10) and carci- 
noembryonic antigen (11). The presence of  oncofetal chromatin antigens in rat hepatomas 
has also recently been reported by Chiu et al.  (12). The identification and characteriza- 
tion of the various protein components of chromatin where malignant and normal tissues 
differ are of prime importance. If nonhistone proteins do control gene expression, such 
components may be highly relevant to the understanding of normal differentiation and 
cancer. In addition, they may provide new useful tumor markers. 
We report here antigenic differences between the nuclear proteins of normal 
mouse liver and hepatomas and describe a  nuclear protein present in normal 
liver,  but absent in hepatomas.  We also present evidence that this protein is 
identical to the mouse urinary protein (MUP). 
* Supported in part by grants CA 16434 and CA 19894 from the National Cancer Institute. 
1  Abbreviations  used in this paper:  MUP,  mouse urinary  protein; NHP,  nonhistone  protein; 
PCA,  perchloric acid;  PMSF,  phenylmethylsulfonyl  fluoride; SDS,  sodium dodecyl sulfate;  SE 
buffer, 0.075  M NaCI, 0.025  M EDTA, 0.01  M Tris, pH 7.5. 
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Materials and Methods 
Mice.  C57L/J  and C3H/HeJ  mice  (The Jackson  Laboratory,  Bar Harbor,  Maine) with the 
transplantable hepatomas BW7756  and H4,  respectively,  Balb/cJ mice also  from The Jackson 
Laboratory, and mice from two colonies of outbred mice were used. The transplantable hepatomas 
were propagated in male mice. To obtain spontaneous hepatomas, C3H mice were kept until more 
than 1 yr old.  The presence of hepatoma was detected from elevated serum alphafetoprotein 
levels.  2 
Preparation of Nuclear Proteins.  Fresh tissue was used in all preparations. Nuclei were 
prepared by homogenization of liver  tissue in hypotonic buffer  with protoase inhibitors  and 
centrifugation  through  2.4  M  sucrose (13,  14).  The  white  nuclear pellet  was  washed and  extracted 
by three different  procedures. 
TRCHNIqUZ NO. 1.  The  first  technique  was  a modification  of  the  procedure of  Yeoman et  al. (9). 
The nuclear pellet  was resuspended in 0.075  M  NaCl, 0.025  M  EDTA, 0.01  M  Tris,  pH 7.5 (SE 
buffer)  by using 1.0  ml of  buffer  for  each mouse liver  in the initial  preparation.  A sample of  the 
nuclear pellet  was  senicated  to  produce  a whole  nuclear lysate.  The  rest  of  the  nuclei  were  washed 
twice in SE buffer  with 10-min spins at 500  g. The supornates represent the first  and second SE 
washes. The  nuclei  were  then  washed  once  in  0.01  M Tris,  pH 7.5.  This  supernate is  the  Tris  wash. 
The pellet  was then resuspended in 3 M  NaCI-7 M  urea, by using 3 ml per  original  mouse liver. 
This  was stirred  at  4°C for  30  rain  then  dialyzed  against 10  vol  of  0.15  M  NaCI, 0.01  M Tris,  pH 7.5 
with  three  changes  over  a period  of  24  h.  The  histone-DNA  complex  was  centrifuged  out  at  10,000g 
for 30 rain  and the NHP  remained in the supernate. The washes were brought to 10  -3 M  with 
PMSF  (phenylmethylsulfonyl fluoride)  by using I/1oo  volume of  10  -I M  PMSF  in  ethanol. 
TECHNIQUE NO. 2. In the second technique, mouse liver nuclei were first washed in 0.05 M Tris, 
pH 7.5, 0.0002 M MgCl2 to give the first Tris wash; then in 0.15 M NaC1, 0.0002 M MgCl~, 0.01 M 
Tris, pH 7.5, to give the 0.15 M NaC1 wash; then in 0.01 M Tris, pH 7.5, 0.0002 M MgCI2 to give the 
second Tris wash. The pellet was resuspended in 2 M NaCI, 0.0002 M MgC12, 0.01 M Tris, pH 7.5, 
and a  sample of this represented the 2 M NaCI extract. The remainder was centrifuged at 5,000 g 
for 10 rain to pellet the nuclear matrix proteins (13). These were washed four more times in the 2 M 
NaC1 buffer to give nuclear matrix.  The 2  M  NaCI extracted chromatin was diluted to 0.15  M 
NaC1, allowed to sit in the cold for 20 rain, and the DNA-histone precipitate centrifuged at 10,000 g 
for 10 rain. The supernate represents the nonhistone proteins. 
To obtain a cytoplasmic extract one mouse liver was homogenized in 0.01 M Tris, pH 7.5, 0.0001 
M CaSO4, 0.001 M MgCls, 0.0001 M NaHSOs,  1 pg/ml soybean trypsin inhibitor (14).  The homo- 
genate was centrifuged at 10,000 g  for 10 rain, and the supernate then centrifuged at 100,000 g  for 
lb. 
All fractions were brought to 10  -s M with PMSF and dialyzed overnight against several changes 
of distilled water. 
TECHNIQUE NO. 3.  A sample of the nuclei was sonicated to provide a  whole nuclear lysate. The 
rest of the nuclei were washed twice in saline-EDTA, once in 0.01 M Tris, pH 7.5, and once in 0.035 
M NaC1, 0.01 M Tris, pH 7.5. The final pellet was resuspended in distilled water and sonicated. 
The protein extracts were either examined as is or lyophilized. The dry proteins were taken up 
in distilled water, or, if not completely soluble, in 8 M urea and 50 mM Tris. This was diluted to 
give a solution of 4 mg/ml in 2 M urea for immunodiffusion tests and 1:50 or more for radioimmu- 
noassays. 
Purification Procedures.  Perchloric acid (PCA) extraction of normal liver and hepatoma tissue 
was performed  as follows:  the tissue was mixed  with an equal  volume of distilled water and 
homogenized in a  Waring blender or a  glass homogenizer. An equal vol of 1.2 M PCA was added 
and the precipitate was removed by centrifugation. The supernate was dialysed against water and 
lyophilized. Gel filtration was performed in Sephadex G-75 columns equilibrated with 0.05 M Tris- 
HCI, pH 7.5. The column was calibrated with proteins of known molecular weights. Ion exchange 
chromatography was carried out by using DE-52 cellulose (Whatman, Inc., Clifton, N. J.) equili- 
brated with 0.02 M sodium phosphate, pH 7.5, and eluted with a linear gradient of 0-1 M NaC1 in 
the same buffer. 
Antisera.  Rabbits were  immunized  with  single  cell  suspensions of normal  liver cells  and 
hepatoma cells. The suspensions were obtained from tissues cut into small pieces and incubated 
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with 0.1% collagenase in serum-free medium for 30 min at 37°C. The cell suspension was passed 
through a nylon net and about 0.2 ml of packed cells mixed with complete Freund's adjuvant was 
used for injection of rabbits. The rabbits received three subcutaneous injections at 2-wk intervals, 
after which they were bled, and then injected and bled once a month. 
Immunizations  with purified proteins were carried out with a  similar injection schedule by 
using 0.2 mg of protein per injection. 
Purification  of Antibodies.  An absorbent (15) was prepared by coupling 0.5 mg of the nuclear 
antigen purified from mouse liver to 250 mg of cyanogen bromide-activated Sepharese (Pharma- 
cia,  Uppsala,  Sweden)  according to the manufacturers  instructions.  Antibodies to the normal 
nuclear antigen were purified from an antiserum prepared against whole liver cells as follows: the 
antiserum  (10 ml) was stirred with the insolubilized antigen for 3 h  at room temperature.  The 
particles (about 0.5 ml) were washed three times with phosphate-buffered saline and eluted four 
times with 1 ml of 0.1 M glycine-HC1, pH 2.6.  The eluates were combined, neutralized with 1 M 
Tris, dialysed against distilled water, and lyophilized. 
Immunoassays.  Immunodiffusion plates were cast in a  barbital buffer, pH 7.6.  The nuclear 
protein samples were dissolved in 2 M urea 50 mM with Tris-HCl for testing. PCA extracts and 
fractions  derived  from  them  were  tested  dissolved  in  water.  Since  initial  experiments  indi- 
cated that the immunological reactivity of the antigen was not altered by treatment with urea, 
samples of liver and hepatema tissue were also prepared for radioimmunoassay by extraction with 
urea and salt. Tissues were homogenized in water as described above. The homogenate was made 6 
M with urea, 2 M with NaC1, and 10 -4 M with PMSF. After incubation for 15 rain and removal of 
insoluble material by centrifugation,  the extract was diluted directly for testing in radioimmu- 
noassay. 
Radioimmunoassay of the nuclear antigen was performed by the double antibody method with 
0.05%  gelatin as diluent as described  (16). Purified antigen was labeled with 125I by using the 
ehloramine-T procedure.  A  standard  curve was obtained by using various amounts  of purified 
antigen. The amount of antigen in the standard solution was determined by the Lowry et al. assay 
(17). 
Immunofluorescence was performed as described (18) by using the affinity-purified antibodies 
as  the  first  antibody  and  fluorescent  anti-rabbit  IgG  for  the  visualization  of the  binding  of 
antibodies. The tissues were fixed in 3.5% formaldehyde. The specificity controls included the use 
of normal  rabbit  IgG instead  of the  antibody  and  inhibition of the fluorescence with purified 
antigen. 
Analytical Procedures.  Gel electrophoresis in the presence of sodium dodecyl sulphate  (SDS) 
was done following the procedure of Fairbanks et al.  (19). 
Amino acid analysis was done on samples hydrolysed with 3 N p-toluene sulfonic acid, 0.2% 3- 
(2-aminoethyl)  indole at  ll0°C for 24  h.  The hydrolysates were analysed on a  Beckman  120 C 
amino acid analyser (Beckman Instruments,  Inc., Cedar Grove, N. J.). 
Electrofocusing was carried out by using an LKB Instruments,  Inc., Reckville, Md. 120 ml col- 
umn and ampholines in the pH range of 4-6. 
Results 
Identification  of  Nuclear  Protein  Differences  between  Liver  and  Hepa- 
toma.  Antisera prepared against cells from normal C57L liver and hepatoma 
BW7756  reacted with a number of antigens present in normal liver, hepatoma, 
and serum when tested in immunodiffusion. However, the anti-liver serum gave 
a single precipitate against nuclear protein fractions from normal liver, but did 
not  react  with  similar  fractions  from  hepatoma  (Fig.  1 A).  With  the  anti- 
hepatema serum one precipitin line was produced against the hepatoma nuclear 
protein fraction, but the component detected seemed to be reduced in normal 
liver (Fig. 1 B). The antigenic component present in the nuclear protein fraction 
of normal liver is the subject of this report. 
Purification  of the  Nuclear  Antigen.  Purification of the nuclear antigen 
identified in normal liver was made possible by the observation that it is soluble l¢.  RUOSLAHTI,  g.  ENGVALL,  H.  JALANKO,  AND  D.  1¢.  COMINGS  1057 
FxG.  1.  Immunodiffusion analysis of nuclear protein fractions from normal liver (N) and 
hepatoma tissue (H). A. Antiserum to normal liver cells. B. Antiserum to hepatoma cells. 
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FxG. 2.  Gel filtration of  PCA extract of  normal mouse liver on Sephadex G-75. The marked 
peak contained  the nuclear antigen. 
in 0.6  M  PCA. This enabled us to start the purification by PCA extraction of 
whole  liver.  About  200  mg  of extract  was  obtained  from  50  mouse  livers. 
Immunodiffusion  indicated that nuclear antigen was a major component of such 
an extract.  Subsequent quantitation with radioimmunoassay has shown that 
about 10% of the PCA extract consists of  this antigen. The same component was 
found in several liver preparations from three different mouse strains and two 
colonies of out-bred mice. 
In gel filtration of the PCA extract on Sephadex G-75, the antigenic activity 
coincided with a major optical density peak (Fig. 2).  Comparison of its elution 
position  with  standard  proteins  indicated a  mol  wt  of about  25,000  for the 
antigen.  SDS-polyacrylamide gel  electrophoresis of the  protein  in  this peak 
revealed a  major band with an approximate tool wt of about 20,000 and a  few 
minor  bands.  Purification  of the  antigen  to  homogeneity was  achieved  by 
chromatography on DEAE cellulose. In ion exchange chromatography it eluted 
as a sharp peak at NaC1 concentration of about 0.4 M  (Fig. 3). Electrofocusing 
gave an optical density peak with coinciding immunoreactivity at pH 4.50.  A 
minor fraction of immunoreactivity was found between pH 4.75  and 5.50  (not 
shown). 1058  LIVER  NUCLEAR  PROTEIN  ABSENT  IN  HEPATOMAS 
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FIG.  3.  Ion exchange chromatography on DEAE  cellulose.  A  15-ml column was equili- 
briated with 0.02 M phosphate buffer at pH 7.5. A 20-mg sample of partially purified nuclear 
antigen from gel filtration (Fig. 2) was applied, and the column was eluted with the starting 
buffer (50 ml) and a 200 ml 0-1 M NaC1 linear gradient (arrow) in the same buffer. The anti- 
gen elutes at a  NaCI concentration of about 0.4 M. 
Antigen obtained from the ion exchange chromatography peak gave a single 
band on SDS gels  (Fig.  4). Comparison of  its mobility  with standard proteins 
indicated  a tool  wt  of  21,000.  Amino acid  analysis  revealed  an  absence  of  proline 
and  abundance of  the  acidic  amino acids  (Table  I).  The ratio  of  the acidic  (Glx + 
Asx) to  basic  amino acids  was 1.95.  No amino sugars were detected.  The lack  of 
carbohydrate was confirmed by a carbohydrate analysis,  which established  the 
carbohydrate content of  the antigen as less  than 0.5%.  Absorbance of  an 0.1% 
solution  at 278 nm with I cm light  path was 0.600. 
Subcellular  Distribution  of  the  Nuclear  Antigen.  The antigen was quanti- 
tated  in  the  nuclear washes and protein  fractions  by  using  a radioimmunoassay 
capable  of  measuring i  ng/ml  of  this  protein.  These  assays  of  the various  nuclear 
subfractions  produced  by technique nos.  1-3 indicate  that  it  is  a nuclear protein 
loosely  bound to  chromatin (Tables  If-IV).  In  technique no. i  all  of  the  contami- 
nating cytoplasmic proteins  were washed out of  nuclei  in the first  and second 
SE wash (14),  and a subsequent Tris  wash showed the highest  specific  activity. 
Most of the antigen was extracted in the various nuclear washes, and the 
specific  activity  was low in the NHP  supernate, which represents  the proteins 
more tightly  bound to  the chromatin. There was essentially  no antigen present 
in the DNA-histone pellet. 
In technique no. 2 the cytoplasm was assayed and found to have a relatively 
low specific  activity  compared to the 0.15  M  NaCl nuclear wash. The specific 
activity  was intermediate for the first  Tris  wash of the nuclei which would 
remove most contaminating cytoplasmic proteins  (14).  The specific  activity  of 
the  0.15  M NaCI wash  was 14-fold  greater  than  that  of  the  cytoplasm  and  at  least 
8-fold  greater  than the 2 M  NaCl extracted  chromatin, the nuclear matrix, the 
DNA-histone, and the NHP. 
Technique no. 3 confirmed the results  with technique no. 1. Here again,  the 
highest  specific  activity  was obtained with the Tris  wash long after  most of  the 
nuclear sap protein  has been washed out of  the nucleus (14). E.  RUOSLAHTI,  E.  ENGVALL,  H.  JALANKO,  AND  D.  l¢.  COMINGS  1059 
FIG.  4.  Polyacrylamide gel electrophoresis in the presence of SDS. The gel sample con- 
tained 50 ~g of purified nuclear antigen. The positions of molecular weight standards run 
on companion gels are shown. A gel with high load of protein is shown to allow evaluation of 
the degree of purity.  The molecular weight was evaluated from gels where lower loading 
gave a  narrower band.  1. Carbonic anhydrase  (mol wt 32,000).  2.  fl-lactoglobulin (mol wt 
18,000).  3.  Lysozyme (mol wt 14,500). 
Similar results were obtained on repeated experiments. No reactions were 
obtained when the nuclear washes and the NHP fraction were tested in immuno- 
diffusion against anti-normal mouse serum and anti-mouse albumin. 
In immunofluorescence of liver tissue with purified antibodies the antigen 
was found to localize  mainly in  the  hepatocyte nuclei  (Fig.  5).  A  granular 
distribution was observed suggesting that it may be bound to specific structures 
within the nuclei. 
Tissue Distribution  of the Nuclear Antigen.  Tissue distribution of the anti- 
gen  was  studied  by  using radioimmunoassay of PCA  and  urea  extracts  of 
various mouse tissues (Table V).  Of the tissues tested, the highest concentra- 
tion was found in the liver. Lower levels were found in other organs. Hepatomas 
showed a much lower concentration of the antigen than liver tissue. Only trace 
amounts were found in PCA extracts of  two transplantable and one spontaneous 1060  LIVER  NUCLEAR  PROTEIN  ABSENT  IN  HEPATOMAS 
T*SL~  I 
Amino Acid Composition of Purified Nuclear Antigen 
Moles/mole of protein 
Amino acid 
(mol wt 21,000)* 
Tyr  3.9 
Phe  9.8 
Trp  0.5 
Lys  13.3 
His  4.9 
Arg  8.3 
Asp  28.5 
Thr  9.9 
Ser  14.0 
Glu  30.2 
Pro  0 
Gly  12.3 
Ala  12.8 
l/s Cys  1.8 
Val  7.3 
Met  2.6 
Ile  8.8 
Leu  17.0 
Amino sugars  0 
* Mean of two determinations. 
TABLE II 
Nuclear Antigen Content in Normal Mouse Liver Fractionated 
by Technique No. 1 
Fraction 
ng antigen~rag protein 
Nuclei  60 
First SE wash  250 
Second SE wash  130 
Tris wash  470 
NHP supernate  30 
DNA-histone pellet  <3 
T.,.nLE  III 
Nuclear Antigen Content in Normal Mouse Liver Fractionated 
by Technique No. 2 
Fraction 
ng antigen~rag protein 
Cytoplasm  270 
First Tris wash  700 
0.15 M  NaC1 wash  3,900 
Second Tris wash  1,600 
2 M NaCI extract  390 
Nuclear matrix  <300 
DNA-histone  <300 
Nonhistone protein  460 E.  RUOSLAHTI,  E.  ENGVALL,  H.  JALANKO,  AND  D.  m.  COMINGS 
TABLE IV 
Nuclear Antigen Content in Normal Mouse Liver Fractionated 
by Technique No. 3 
Fraction 
ng antigen~rag protein 
Whole nuclei  530 
First SE wash  830 
Second SE wash  750 
First Tris wash  1,220 
0.035 M NaC1 wash  910 
Washed nuclear pellet  400 
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hepatoma. Extraction  of  the  C3H transplantable  hepatoma with  6 M urea  and 2 
M  NaCI revealed  2% of  the amount of  antigen found  in  similar  extracts  of  liver 
tissue  from male C3H mice (Table VI). Similar extraction  of a spontaneous 
hepatoma of  a C3H mouse revealed antigen concentrations  of  30 and 1,730  ~g/ 
mg of  protein  in  the tumor and the rest  of  the  liver  of  this  mouse, respectively. 
Hepatoma nuclear protein preparations similar  to the ones shown in Fig. 1 
(technique  no. 1) did not have antigen detectable  by radioimmunoassay. This 
excluded the presence of  more than 1% of  the level  present in similar  prepara- 
tions from normal liver.  The absence of significant  amounts of the nuclear 
antigen in  hepatomas was further  evidenced by  the  lack  of  antibodies  against  it 
in  the antiserum  prepared  aginst  single  cell  suspensions  of  hepatoma BW 7756. 
While  the  antiserum  prepared  against  liver  cells  bound  significant  radioactivity 
from the 1~I-labeled  antigen up to a dilution  1:10  e, the anti-hepatoma serum 
showed no  binding  diluted  1:100,  the  highest  concentration  tested.  Immunofluo- 
rescence  also  suggested the presence of  decreased amounts of  the antigen in a 
spontaneous hepatoma (Fig.  5). 
Nuclear  Antigen  in  Blood  and  Urine.  Similarity  to  MUP.  The nuclear 
antigen was found to be present in the blood and urine (Table VII). The levels 
found in male mice were generally higher than those of females, but the large 
variation present resulted in overlapping ranges of blood  concentrations for 
males and females. 
The high urinary concentrations (up to 13 mg/ml) prompted us to study the 
relationship of  the nuclear antigen to the mouse urinary protein, MUP (20). MUP 
constitutes the main part of protein in normal mouse urine and is known to 
originate from the liver (21). Its mol wt is close to 20,000 (22, 23), similar to that 
of the nuclear antigen.  In keeping with earlier results (23), fractionation of 
mouse urine on Sephadex G-75 resulted in a distinct peak at mol wt of about 
25,000. The elution volume of this peak was the same as that of the nuclear 
antigen.  The protein in this peak reacted identically with the liver nuclear 
antigen when tested in immunodiffnsion (Fig. 6). 
Discussion 
The results of this study conf~m that immunechemically detectable differ- 
ences exist between the nuclear proteins of normal and malignant tissue (6-9). 
It was rather surprising that the antisera we prepared against whole cells from 1062  LIVER  NUCLEAR  PROTEIN  ABSENT  IN  HEPATOMAS 
Fro.  5.  Localization of nuclear antigen in sections of normal mouse liver and a sponta- 
neous C3H hepatoma by immunofluorescence. The antigen is mainly found in the nuclei 
with some staining of the cytoplasm. Weaker staining of the hepatoma nuclei is evident. (A) 
Normal liver stained with anti-nuclear antigen.  (B) Spontaneous hepatoma stained with 
anti-nuclear antigen. (C) Normal liver stained with normal rabbit serum as a control. (D) 
Higher  magnification of a  single nucleus  from  normal  liver stained  with  anti-nuclear 
antigen. The controls also included neutralization of the antibody with purified antigen. 
This abolished the fluorescence. 
normal liver reacted only with a single component in the liver nuclear proteins. 
This antigen was not detectable in hepatoma nuclear protein preparations.  The 
antigen(s) detected in the hepatoma nuclear proteins will be studied further, but 
present results indicate that  the antiserum  prepared against whole hepatoma 
cells  detected  a  single  component.  This  antigen  was  detectable  in  nuclear 
proteins from two hepatomas,  one of which was the source of the immunogen, 
but seemed to be present in lower amounts in the nuclear protein fractions from 
normal liver. 
Nuclear protein preparations are known to contain up to 500 different proteins 
detectable  by two-dimensional  electrophoresis.  It  may be that  most  of these E.  RUOSLAHTI~  E.  ENGVALL,  H.  JALANKO,  AND  D.  E.  COMINGS 
TASL~  V 
Nuclear Antigen Content in PCA Extracts of Various Normal 
Tissues and Hepatomas 
Sample 
Izg antigen~rag protein 
Mouse liver 1  109 
....  2  119 
"  BW7756  hepatoma (C57L/J)  0.4 
"  H4 hepatoma (C3H/HeJ)  0.05 
"  Spontaneous hepatoma (C3H/HeJ)  <0.1 
"  Lung 1  2.0 
....  2  6.0 
"  Spleen  0.8 
"  Stomach  4.8 
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TABLE VI 
Nuclear Antigen Concentration of Urea-NaCl Extracts of 
Normal Liver and Hepatomas 
Tissue 
ng antigen/rag protein 
Normal Liver male C3H 1  1,890 
....  2  3,890 
....  3  2,440 
....  4*  1,730 
....  female  1  730 
2  410 
3  1,000 
Transplantable C3H hepatoma H4 
Spontaneous C3H hepatoma* 
* Liver and tumor from the same mouse. 
80 
30 
TABLE  VII 
Nuclear Antigen Concentration  in Mouse Serum and Urine 
Sample  Strain and sex 
Antigen concentration 
Mean  Range 
~g/ml 
Serum  C3H/HeJ male  24.4  2.4-58.0 
"  C3H/HeJ female  9.7  3.5-24.0 
"  C57L/J male  14.0  1.8-38.0 
Urine  C3H/HeJ male  8,100  3,500-13,100 
"  C3H/HeJ female  1,600  300-2,550 
"  C57L/J male  6,900  5,900-7,900 
proteins are present in concentrations too low to elicit an antibody response or to 
be detectable by immunodiffusion. It is also possible that the proteins we have 
detected  represent  a  particularly  immunogenic  subclass  of nuclear  proteins. 
Finally, it is possible that  these proteins are unusual  in that they are not only 
present in high concentrations in the nucleus but are also present in significant 1064  LIVER  NUCLEAR PROTEIN  ABSENT  IN  HEPATOMA8 
FxG. 6.  Immunodiffusion analysis of the nuclear antigen purified from liver 500 ~g/ml (A) 
and MUP complex isolated from mouse urine by gel filtration (23) 250 pg/ml (B). Tested 
against antiserum to purified nuclear antigen, 
concentrations  in  the  cytoplasm.  Thus  they  have  a  higher overall  concentration 
in  whole cells  than proteins  present  only in  the nucleus.  As could  be  expected, 
our  antisera  reacted  with a  number of  other  components  present  in  cytoplasmic 
proteins  or serum. Whatever the reason for their  apparent specificity  of  our 
antisera  when reacted  against nuclear proteins,  the results  demonstrate the 
usefulness of immunochemical techniques in the identification  of individual 
nuclear proteins. 
The identification,  isolation,  and characterization  of a nuclear NHP  from 
normal liver  reported  here provides  new information about a protein  different 
from  any  of  the  few  nuclear  proteins  previously  isolated.  Its  amino  acid  composi- 
tion  and/or  molecular weight  differ  from  those  of  the  HMG  proteins  (24-26),  A24 
(27),  and from those of  the J2 protein  recently  identified  in the mouse liver 
nuclei.  3  However, it is apparent that the nuclear protein  we describe  here is 
closely  related,  if  not identical,  to  mouse urinary protein,  MUP  (20). 
Mice, unlike  humans, excrete  a large  amount of  protein  consisting  mainly of 
MUP  in  the urine (20-23).  It  is  known that  MUP  is  also  present  in  serum, and 
that  it  originates  in  the  liver  (21).  Genetic  variation  occurring  in  this  protein  has 
been  used as  a marker to  study genetically  mosaic  liver  (28).  The expression  of 
MUP  is partly  sex-dependent, with higher expression in males. Testosterone 
treatment  of  castrated  females  brings  their  MUP  expression  to  male level  (20). 
We found  the  nuclear  protein  antigen  to  share  several  of  these  properties  with 
MUP. Concentrations  up  to  13  ~g/ml  were  present  in  the  urine,  and  the  antigen 
made up 50-90% of  the nondialysable material in urine.  The serum levels  of 
MUP  have  been  reported  to  be  50-150  and  10-20  ~g/ml  in  male  and  female  mice, 
respectively  (29).  We found similar  serum concentrations  for  the nuclear pro- 
tein, including  the sex difference  observed for MUP.  Our results  indicate  a 
larger  variation  in these levels  than those previously  reported  for MUP  (21). 
Like  MUP, our  protein  appeared  to  be  present  predominantly  in  the  liver.  While 
the smaller  amounts of  nuclear antigen we found  in  various  other  organs  could 
originate  from the blood and tissue  fluid  present in these organs, a low level 
expression of the nuclear antigen in organs other than the liver  cannot be 
excluded.  The  tool  wt  of  MUP  has  been  reported  to  be  17,500  (23)  and  20,000  (22). 
These values are in an agreement with our estimate of  21,000  for  the nuclear 
3  B. J. Conner and D. E. Comings. Nuclear proteins IV. Studies of  histone-binding proteins 
from mouse liver  by affinity  chromatography. Manuscript submitted for  publication. E.  RUOSLAHTI,  E.  ENGVALL,  H.  JALANKO,  AND  D.  E.  COMINGS  1065 
antigen. These similarities in the expression and molecular properies of MUP 
and the nuclear antigen we describe clearly show that the two proteins are 
related if not identical. The function of MUP is not known. It has been suggested 
that it could be involved in the transportation of testosterone or its metabolites 
to the urine. Measurement of binding of the hormone by this protein, however, 
revealed a  very low association constant (30). To our knowledge the nuclear 
localization of MUP has not been reported before. 
Apart from being nuclear protein, our antigen shows the interesting charac- 
teristic of being absent from malignant hepatocytes. Our results show that two 
transplantable hepatomas and three different spontaneous hepatomas have less 
than 2% of the amount present in normal liver tissue of mice corresponding 
strains. The amount in hepatomas is comparable to what we found in organs 
other than the liver and at least partly originates from the blood present in the 
tumor tissues. This suggests a virtual absence of the antigen in hepatomas. The 
transplantable hepatomas used in this study may have accumulated a number 
of biochemical changes unrelated to the expression of malignancy during the 
many in vivo passages they have been through. It is therefore significant that 
spontaneous hepatomas,  which are  more likely to  represent a  malignancy- 
associated  deviation  from  the  normal  phenotype,  also  showed  a  decreased 
amount of the antigen. 
The loss of normal components is a well established phenomenon for various 
tumors, including hepatomas (31). The nuclear localization and hormone de- 
pendence of MUP suggest that it could have a regulatory function in mainte- 
nance of the normal phenotype of liver cells. 
Summary 
A nuclear antigen was detected in the mouse liver nonhistone protein fraction 
by using antibodies to whole liver cells. The antigen was purified to homogene- 
ity from perchloric acid extracts of liver tissue. It gave a single band correspond- 
ing to tool wt 21,000 in sodium dodecyl sulfate gel electrophoresis. Amino acid 
and carbohydrate analysis showed predominance of the acidic amino acids, lack 
of proline, and absence of carbohydrate. 
Immunofluorescence  staining of liver sections confirmed the nuclear localiza- 
tion of the antigen. Its tissue distribution was studied by using radioimmunoas- 
say. Of  the various tissues extracted for analysis, the liver contained the highest 
amounts of  the antigen, about 1 ~g/mg ofsolubilized liver protein. Other tissues 
examined showed 2-4%  of the amount of antigen present in  the liver.  Two 
transplantable hepatomas in C3H/HeJ and C57L/J mice, respectively, and three 
spontaneous C3H  hepatomas showed greatly decreased levels of the antigen 
compared to normal liver.  The amount of antigen in hepatomas varied from 
nondetectable to 2% of  the amount of antigen found in the livers of the mice. The 
antigen was also found in the blood. 
The antigen was found in high concentrations (up to 13 mg/ml) in the urine of 
normal mice. This suggests identity with the previously known mouse urinary 
protein (MUP). In addition to the extremely  high urinary output, the properties 
found to be shared by MUP and the nuclear antigen included similar serum 
concentrations (2-60/~g/ml), a sex difference  with lower values in females, same 1066  LIVER  NUCLEAR  PROTEIN  ABSRNT  IN  HEPATOMAS 
molecular size as determined by gel filtration, and immunological identity. The 
nuclear localization of MUP and its disappearance from hepatomas suggest that 
it may have an important regulatory function. 
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